Concepedia

Selena Daniels

SD

15

Publications

746

Citations

14

H-Index

2014

Active since

Affiliations

Allergan (United States)(Current)

United States Food and Drug Administration

Laguna Research

Center for Drug Evaluation and Research

Ithaka Harbors

Selena Daniels is an author at Allergan (United States) specializing in clinical trials, cancer research, and medicine.

Top concepts

Publications per year

2014–2021

15

Publications

15

Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop

Paul G. Kluetz, Bindu Kanapuru, Steven J. Lemery et al. · Value in Health · 2017 · 120 citations

, , +8

FDA Approval Summary: Selumetinib for Plexiform Neurofibroma

Denise Casey, Suzanne Demko, A. K. Sinha et al. · Clinical Cancer Research · 2021 · 99 citations

U.S. Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer

Harpreet Singh, Amanda J. Walker, Laleh Amiri‐Kordestani et al. · Clinical Cancer Research · 2018 · 96 citations · Full text

Racial differences in clinical characteristics, perceptions and behaviors, and psychosocial impact of adult female acne.

Valerie Callender, Andrew Alexis, Selena Daniels et al. · PubMed · 2014 · 74 citations

Understanding the burden of adult female acne.

Emil Tanghetti, Ariane K. Kawata, Selena Daniels et al. · PubMed · 2014 · 66 citations · Full text

Rows per page

1–5 of 15